213309 Danger on the Road: The impact of transportation policy on childhood injury

Tuesday, November 10, 2009: 4:50 PM

Sally Fogerty, RN, MEd , Health and Human Development Division, Education Development Center, Inc., Newton, MA
Transportation determines where we live, work, shop, and enjoy leisure. It affects our stress levels and the time we spend with our children. Although most people don't think of it as a key determinant of health, transportation has far-reaching implications for our risk of disease and injury.

Automobile crashes are the leading cause of death due to unintentional injury for children under 14 in the US; bicycles are second only to autos as a factor in childhood injury. Government policy, social norms and family choice all play a role in shaping the extent and nature of injury risk due to transportation at the household level. This presentation will review current data on transportation –related injury as it affects family health, and consider the potential impact of changes in transportation policy.

Learning Objectives:
• Identify three major injury related outcomes of current transportation policy; • Identify three ways in which transportation policy shapes family well-being

Keywords: Injury Prevention, Child/Adolescent

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Sally Fogerty has been Deputy Director of HHD’s Center for the Study and Prevention of Injury, Violence, and Suicide since 2008. She is involved in developing prevention programs, trainings, and materials to reduce and prevent both intentional and unintentional injuries. Ms. Fogerty is also the Director of the Children’s Safety Network, a project within this Center that focuses on integrating injury and violence prevention across programs in state health departments, particularly maternal and child health programs.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.